Evidence map›Paper›PMID 26903479›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Shortened Intervals during Heterologous Boosting Preserve Memory CD8 T Cell Function but Compromise Longevity.

Emily A Thompson, Lalit K Beura, Christine E Nelson, Kristin G Anderson, Vaiva Vezys

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Controlling timing and location in vaccines.Advanced drug delivery reviews · 2020
    Pooled it
  2. Article
  3. Review
  4. Oral mucosal vaccination using integrated fiber microneedles.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. CD4The Journal of experimental medicine · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emily A ThompsonDepartment of Microbiology and Immunology, Center for Immunology, University of Minnesota, Minneapolis, MN 55455;ORCID http://orcid.org/0000-0002-4383-5249
Lalit K BeuraDepartment of Microbiology and Immunology, Center for Immunology, University of Minnesota, Minneapolis, MN 55455;ORCID http://orcid.org/0000-0002-8597-3949
Christine E NelsonDepartment of Microbiology and Immunology, Center for Immunology, University of Minnesota, Minneapolis, MN 55455;
Kristin G AndersonDepartment of Microbiology and Immunology, Center for Immunology, University of Minnesota, Minneapolis, MN 55455; Division of Oncology, Department of Medicine, University of Washington, Seattle, WA 98109; and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.ORCID http://orcid.org/0000-0001-9263-4438
Vaiva VezysDepartment of Microbiology and Immunology, Center for Immunology, University of Minnesota, Minneapolis, MN 55455; vvezys@umn.edu.

Funding

IMMUNOLOGY TRAINING PROGRAMT32AI007313 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Carla Rothlin · 1989 to 2026
$5.7M
Analysis of Stem Cell Dynamics and Differentiation By Cellular BarcodingDP2OD006472 · OD · BOSTON CHILDREN'S HOSPITAL · PI CAMARGO, FERNANDO · 2009 to 2009
$2.6M
Understanding the Persistence of Immune-mediated Chronic DiseasesDP2OD006473 · OD · UNIVERSITY OF MINNESOTA · PI VEZYS, VAIVA D · 2009 to 2009
$2.3M
NIAID NIH HHS T32 AI007313NIAID NIH HHS T32AI007313NIH HHS DP2 OD006472NIH HHS DP2 OD006473NIH HHS DP2OD006473
6 · The paper itself

Abstract

Developing vaccine strategies to generate high numbers of Ag-specific CD8 T cells may be necessary for protection against recalcitrant pathogens. Heterologous prime-boost-boost immunization has been shown to result in large quantities of functional memory CD8 T cells with protective capacities and long-term stability. Completing the serial immunization steps for heterologous prime-boost-boost can be lengthy, leaving the host vulnerable for an extensive period of time during the vaccination process. We show in this study that shortening the intervals between boosting events to 2 wk results in high numbers of functional and protective Ag-specific CD8 T cells. This protection is comparable to that achieved with long-term boosting intervals. Short-boosted Ag-specific CD8 T cells display a canonical memory T cell signature associated with long-lived memory and have identical proliferative potential to long-boosted T cells Both populations robustly respond to antigenic re-exposure. Despite this, short-boosted Ag-specific CD8 T cells continue to contract gradually over time, which correlates to metabolic differences between short- and long-boosted CD8 T cells at early memory time points. Our studies indicate that shortening the interval between boosts can yield abundant, functional Ag-specific CD8 T cells that are poised for immediate protection; however, this is at the expense of forming stable long-term memory.

Indexed as

Immunization, SecondaryImmunologic MemoryVaccinationAnimalsAntigensBacterial VaccinesCD8-Positive T-LymphocytesCell MovementEpitopes, T-LymphocyteMiceMice, TransgenicModels, AnimalPhenotypeTime FactorsViral VaccinesAntigensBacterial VaccinesEpitopes, T-LymphocyteViral Vaccines

Identifiers

PMID26903479
PMCPMC4799748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.